Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

BACKGROUND: The majority of breast cancer patients in Jordan are diagnosed at a young age and present with metastatic or locally advanced disease. The National Surgical Adjuvant Breast and Bowel Project Protocol B27 (NSABP-B27) (four cycles of adriamycin and cyclophosphamide [AC] followed by four cy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Onco Targets Ther
Main Authors: Abdel-Razeq, Hikmat, Saadeh, Salwa S, Abu-Nasser, Mahmoud, Abdulelah, Hazem, Marie, Lina, Salam, Murad, Ali, Basel Al-Haj, Ibrahim, Mohammad, Rimawi, Dalia
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905529/
https://ncbi.nlm.nih.gov/pubmed/29695917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S151821
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares